MedTrace Logo

Optimize RV Follow-up Selective Site Pacing Clinical Trial

NCT00949715 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2018-02-15

Study results available
· View outcomes & findings →

Summary

The purpose of the Optimize RV Follow-Up study is to determine the long-term effect of selective site pacing. Selective site pacing refers to which area of the right ventricle the lead is placed. The goal of selective site pacing is to improve how the heart contracts when paced.

Conditions

  • Cardiac Pacing
  • Right Ventricular Pacing
  • Left Ventricular Ejection Fraction

Interventions

DEVICE

Medtronic or Vitatron Dual-Chamber Pacemaker

A Medtronic or Vitatron market-approved dual-chamber implantable pulse generator (IPG) with atrial tachycardia/atrial fibrillation (AT/AF) trending ability

DEVICE

Medtronic SelectSecure 3830 Lead

Medtronic market-approved SelectSecure Model 3830 bipolar pacing lead

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Optimize RV Follow-Up Team · Medtronic

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2011-04-30
Completion
2011-12-31

Countries

  • United States
  • Israel
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00949715 on ClinicalTrials.gov